Publicacións (22) Publicacións de Cristina Mondelo Garcia

filter_list

2025

  1. Development of a UHPLC-UV/Vis Method for Simultaneously Determining Six Beta-Lactam Antibiotics in Plasma: A Tool for the Clinical Implementation of Therapeutic Monitoring of Beta-Lactams

    Antibiotics, Vol. 14, Núm. 6

  2. Influence of ABCB1 polymorphisms on aripiprazole and dehydroaripiprazole plasma concentrations

    Scientific Reports, Vol. 15, Núm. 1

2024

  1. Artificial Intelligence and Machine Learning Applications to Pharmacokinetic Modeling and Dose Prediction of Antibiotics: A Scoping Review

    Antibiotics, Vol. 13, Núm. 12

  2. Head-to-Head Comparison of UHPLC-MS/MS and Alinity C for Plasma Analysis of Risperidone and Paliperidone

    Pharmaceuticals, Vol. 17, Núm. 11

  3. Towards Precision Medicine in Clinical Practice: Alinity C vs. UHPLC-MS/MS in Plasma Aripiprazole Determination

    Pharmaceutics, Vol. 16, Núm. 1

  4. Towards precision medicine of long-acting aripiprazole through population pharmacokinetic modelling

    Psychiatry Research, Vol. 333

2023

  1. Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy

    Pharmaceutics, Vol. 15, Núm. 8

  2. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence

    Pharmaceutics, Vol. 15, Núm. 11

  3. Design and biopharmaceutical preclinical characterisation of a new thermosensitive hydrogel for the removal of gastric polyps

    International Journal of Pharmaceutics, Vol. 635, pp. 122706

  4. Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial

    Pharmaceutics, Vol. 15, Núm. 2

  5. Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies’ Determination against ELISA

    Pharmaceutics, Vol. 15, Núm. 11

  6. Estudio farmacocinético de adalimumab intravítreo en un modelo de rata con uveítis mediante PET

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  7. Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review

    Pharmaceutics, Vol. 15, Núm. 3

2022

  1. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

  2. Elaboración de medicamentos personalizada en los Servicios de Farmacia Hospitalaria: ¿Quo vadis?

    Revista de la OFIL, Vol. 32, Núm. 1, pp. 87-88

  3. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

  4. Recent Advances in Proteomics-Based Approaches to Studying Age-Related Macular Degeneration: A Systematic Review

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2019

  1. ¿Cuál es la dosis óptima de clopidogrel en pacientes pediátricos?

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 90, Núm. 4, pp. 219-223

2018

  1. Evidencia de los beneficios de Nexobrid® en quemaduras profundas

    Proyecto Lumbre: Revista Multidisciplinar de Insuficiencia Cutánea Aguda, Mes 16, pp. 76-80

  2. Refractory orthostatic hypotension in a patient with a spinal cord injury: Treatment with droxidopa

    Journal of Spinal Cord Medicine, Vol. 41, Núm. 1, pp. 115-118